Introducing Spikevax XBB.1.5 from Moderna
COVID-19 isn’t giving up – and neither are we.1,2Especially for your at-risk patients.1,2 The Omicron subvariant XBB.1.5 has shown to be more transmissible than some…
COVID-19 isn’t giving up – and neither are we.1,2Especially for your at-risk patients.1,2 The Omicron subvariant XBB.1.5 has shown to be more transmissible than some…
While GLP-1 RAs are the usual first injectable therapy for T2D in Australia, many patients will need further intensification with treatment such as insulin, especially…
Adherence to medication treatment is a growing issue, with up to 60% of patients discontinuing antidepressant treatment within 3 months.1 Adherence to antidepressants is crucial…
This article was written by AusDoc’s commercial team for Galderma Acne vulgaris is a chronic, multifactorial inflammatory disease and may have profound negative emotional and…
Mark Butler, Minister for Health, has announced that a ban on the importation of disposable vapes will commence on 1 January 2024. In parallel with…
Becoming an Authorised Prescriber (AP) is only the first step in successfully prescribing NVPs to your patients. In order to streamline the prescribing process, Liber…
This content is produced and promoted by Servier A National Hypertension Taskforce has been established to improve Australia’s BP control rate from32% to 70% by…
1 in 2 people with T2DM are not at target HbA1c1 Real-world and RCT evidence supports Toujeo (insulin glargine 300 U/mL) for balancing efficacy in…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.